StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho total assets

Total assets on the balance sheet at the end of each period.

QuidelOrtho's total assets was $5.78B at Sep 27, 2026. For fiscal 2025 it was $5.77B, down 10.2% from the year before. The highest annual figure on record is $8.86B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 28, 2025$5.77B-10.2%
FY2024Dec 29, 2024$6.42B-25.0%
FY2023Dec 31, 2023$8.56B-3.3%
FY2022Jan 1, 2023$8.86B+264.4%
FY2021Jan 2, 2022$2.43B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$5.78B+1.9%
Q2 FY2026Jun 28, 2026$5.72B-10.4%
Q1 FY2026Mar 29, 2026$5.63B-12.9%
Q4 FY2025Dec 28, 2025$5.77B-10.2%
Q3 FY2025Sep 28, 2025$5.68B-16.6%
Q2 FY2025Jun 29, 2025$6.38B-4.6%
Q1 FY2025Mar 30, 2025$6.46B-3.6%
Q4 FY2024Dec 29, 2024$6.42B-25.0%
Q3 FY2024Sep 29, 2024$6.80B-20.4%
Q2 FY2024Jun 30, 2024$6.69B-21.8%
Q1 FY2024Mar 31, 2024$6.70B-23.7%
Q4 FY2023Dec 31, 2023$8.56B-3.3%
Q3 FY2023Oct 1, 2023$8.54B-1.3%
Q2 FY2023Jul 2, 2023$8.55B-3.1%
Q1 FY2023Apr 2, 2023$8.79B+261.5%
Q4 FY2022Jan 1, 2023$8.86B–
Q3 FY2022Oct 2, 2022$8.66B–
Q2 FY2022Jul 3, 2022$8.82B–
Q4 FY2021Jan 2, 2022$2.43B–

More QuidelOrtho figures

See a number that looks wrong?